Oct 03, 2011, 03.56 PM | Source: Moneycontrol.com
Vivimed Labs has acquired entire equity stake in Kolkata-based privately held pharma company Klar Sehen to boost its domestic presence specialty medicine areas.
Vivimed Labs has acquired entire equity stake in Kolkata-based privately held pharma company Klar Sehen to boost its domestic presence in specialty medicine areas.
The financial terms of the deal were not disclosed.
The 30-year-old company operates in a niche ophthalmic segment and owns about 50 trademarks and brands like Renicol, Dexacort, Lysicon-V, in eye care, Vivimed said Monday.
Klar Sehen has strong marketing presence in North East, Bihar and Andhra Pradesh, it said. It has manufacturing facilities at Kolkata and Hyderabad and also has arrangements to manufacture some of its products in Uttarakhand, and operates with over 150 medical sales professionals, Vivimed said.
Earlier last month Vivimed had completed the acquisition of Octtantis Nobel, a Hyderabad-based pharmaceutical marketing company.
Vivimed Labs shares were trading up 1.2% at Rs 247.50 on NSE on Monday.
Vivimed Labs stock price
On February 10, 2016, at 10:13 hrs Vivimed Labs was quoting at Rs 406.50, up Rs 0.50, or 0.12 percent. The 52-week high of the share was Rs 485.00 and the 52-week low was Rs 175.00.
The company's trailing 12-month (TTM) EPS was at Rs 8.74 per share as per the quarter ended September 2015. The stock's price-to-earnings (P/E) ratio was 46.51. The latest book value of the company is Rs 230.16 per share. At current value, the price-to-book value of the company is 1.77.
Vivimed Labs may test Rs 500 in 6 months, says SP Tulsian
SP Tulsian of sptulsian.com is of the view that Vi
Top buzzing midcap stocks to trade on January 15
Here are a few top buzzing midcap stocks picked by
Vivimed Labs approves stock split; shares hit 52-week high
In the board meeting held on January 11, 2016, it
Vivimed gets CCI nod to products sale deal with Clariant
Dr Reddys Labs consolidated Dec '15 sales at Rs 3,967.90 crore
Dr Reddys Laboratories has reported a consolidated
Mercury Labs standalone Dec '15 sales at Rs 12.57 crore
Mercury Laboratories has reported a sales total in
Auro Labs standalone Dec '15 sales at Rs 8.57 crore
Auro Laboratories has reported a sales total incom
Buy Divis Labs; target of Rs 1305: Religare
Religare is bullish on Divis Labs Ind has recommen